Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Fatigue in immune-mediated neuropathies.

Merkies IS, Faber CG.

Neuromuscul Disord. 2012 Dec;22 Suppl 3:S203-7. doi: 10.1016/j.nmd.2012.10.014. Review.

PMID:
23182640
2.
3.

Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.

Eldar AH, Chapman J.

Autoimmun Rev. 2014 Apr-May;13(4-5):525-30. doi: 10.1016/j.autrev.2014.01.033. Epub 2014 Jan 13. Review.

PMID:
24434363
4.

Demyelinating inflammatory neuropathies, including Guillain-Barré syndrome.

Steck AJ, Schaeren-Wiemers N, Hartung HP.

Curr Opin Neurol. 1998 Aug;11(4):311-8. Review. Erratum in: Curr Opin Neurol 1998 Dec;11(6):739.

PMID:
9725076
5.

[Diagnosis of immune-mediated neuropathies].

Diószeghy P.

Orv Hetil. 2011 Sep 25;152(39):1560-8. doi: 10.1556/OH.2011.29182. Review. Hungarian.

PMID:
21920842
6.

Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies.

Hartung HP, van der Meché FG, Pollard JD.

Curr Opin Neurol. 1998 Oct;11(5):497-513. Review. No abstract available.

PMID:
9848000
7.

Treatment of immune-mediated, dysimmune neuropathies.

Finsterer J.

Acta Neurol Scand. 2005 Aug;112(2):115-25. Review.

PMID:
16008538
8.

[Dysimmune neuropathies: current diagnosis and therapy].

Léger JM, Larue S, Dashi F.

Rev Prat. 2008 Nov 15;58(17):1887-9, 1892-4. French.

PMID:
19157204
9.

Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.

Franssen H, Straver DC.

Muscle Nerve. 2014 Jan;49(1):4-20. doi: 10.1002/mus.24068. Epub 2013 Dec 3. Review.

PMID:
24037667
10.

Inflammatory neuropathies.

Whitesell J.

Semin Neurol. 2010 Sep;30(4):356-64. doi: 10.1055/s-0030-1267279. Epub 2010 Oct 12. Review.

PMID:
20941668
11.

Diagnosis, epidemiology and treatment of inflammatory neuropathies.

Baig F, Knopp M, Rajabally YA.

Br J Hosp Med (Lond). 2012 Jul;73(7):380-5. Review.

PMID:
22875431
12.

Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale.

van Nes SI, Vanhoutte EK, Faber CG, Garssen M, van Doorn PA, Merkies IS; PeriNomS Study Group.

J Peripher Nerv Syst. 2009 Dec;14(4):268-78. doi: 10.1111/j.1529-8027.2009.00238.x.

PMID:
20021568
13.

Treatment of acute immune-mediated neuropathies: Guillain-Barré syndrome and clinical variants.

Sederholm BH.

Semin Neurol. 2010 Sep;30(4):365-72. doi: 10.1055/s-0030-1267280. Epub 2010 Oct 12. Review.

PMID:
20941669
14.

[Immune-mediated neuropathies].

Stoll G, Reiners K.

Nervenarzt. 2016 Aug;87(8):887-98. doi: 10.1007/s00115-016-0164-3. Review. German.

PMID:
27474733
15.

Anti-GD1a ganglioside antibodies in peripheral motor syndromes.

Carpo M, Nobile-Orazio E, Meucci N, Gamba M, Barbieri S, Allaria S, Scarlato G.

Ann Neurol. 1996 Apr;39(4):539-43.

PMID:
8619533
16.

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.

van Nes SI, Vanhoutte EK, van Doorn PA, Hermans M, Bakkers M, Kuitwaard K, Faber CG, Merkies IS.

Neurology. 2011 Jan 25;76(4):337-45. doi: 10.1212/WNL.0b013e318208824b.

PMID:
21263135
17.

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

Barohn RJ, Saperstein DS.

Semin Neurol. 1998;18(1):49-61. Review.

PMID:
9562667
18.

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: pathogenesis and treatment.

Koski CL.

Semin Neurol. 1994 Jun;14(2):123-30. No abstract available.

PMID:
7984827
20.

Acquired inflammatory demyelinating neuropathies.

Ensrud ER, Krivickas LS.

Phys Med Rehabil Clin N Am. 2001 May;12(2):321-34, ix. Review.

PMID:
11345010

Supplemental Content

Support Center